文献速递创伤与烧伤复苏、休克与脓毒症

创伤患者院前给予氨甲环酸的疗效:随机对照试验的荟萃分析

Efficacy of prehospital administration of tranexamic acid in trauma patients: A meta-analysis of the randomized controlled trials.
PubMed 文献 · Am J Emerg Med · 2018-03-16
一句话结论院前给予氨甲环酸可能降低创伤患者24小时死亡率(OR 0.49,95%CI 0.28–0.85),30天死亡率与血栓栓塞事件无显著差异。

该荟萃分析纳入2项符合标准的研究,评估院前给予氨甲环酸对比安慰剂对严重出血创伤患者结局的影响。汇总结果显示,氨甲环酸组24小时死亡率OR为0.49(95%CI 0.28–0.85),30天死亡率OR为0.86(95%CI 0.56–1.32),血栓栓塞事件OR为0.74(95%CI 0.27–2.07)。作者认为院前氨甲环酸似乎降低创伤患者早期死亡率,30天死亡率与血栓栓塞事件呈降低趋势,但需更多随机对照临床试验确定这些趋势的意义。

要点

  • 院前给予氨甲环酸组24小时死亡率OR 0.49(95%CI 0.28–0.85),较安慰剂组降低。
  • 30天死亡率OR 0.86(95%CI 0.56–1.32),未达统计学显著,呈降低趋势。
  • 血栓栓塞事件OR 0.74(95%CI 0.27–2.07),未达统计学显著,呈降低趋势。
  • 作者认为院前氨甲环酸似乎降低创伤患者早期死亡率,但需更多随机对照临床试验确定趋势意义。

适用人群与场景

  • 严重出血的创伤患者,院前场景。

研究设计与关键结果

  • 研究类型:系统综述与荟萃分析,纳入2项符合标准的研究(原文未明确研究设计类型为RCT或准RCT的具体分布)。
  • 干预与对照:院前给予氨甲环酸对比安慰剂。
  • 主要终点:24小时死亡率OR 0.49(95%CI 0.28–0.85);30天死亡率OR 0.86(95%CI 0.56–1.32);院内血栓栓塞并发症OR 0.74(95%CI 0.27–2.07)。
  • 作者结论:院前氨甲环酸似乎降低创伤患者早期死亡率,30天死亡率与血栓栓塞事件呈降低趋势,需更多随机对照临床试验确定趋势意义。

证据类型、等级与局限

  • 证据类型:系统综述与荟萃分析(基于随机对照试验)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为院前氨甲环酸似乎降低创伤患者早期死亡率,该结论基于2项研究的汇总分析。
  • 作者指出需更多随机对照临床试验确定30天死亡率与血栓栓塞事件趋势的意义。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: Antifibrinolytic agent tranexamic acid (TXA) has a potential clinical benefit for in-hospital patients with severe bleeding but its effectiveness in pre-hospital settings remains unclear. We conducted a systematic review and meta-analysis to evaluate whether pre-hospital administration of TXA compared to placebo improve patients' outcomes?

METHODS: PubMed, MEDLINE, Cochrane Library, WHO International Clinical Trials Registry Platform, Cochrane Central Register of Controlled Trials (CENTRAL), Scopus, clinicaltrials.gov and Google scholar databases were searched for a retrospective, prospective and randomized (RCT) or quasi-RCT studies that assessed the effect of prehospital administration of TXA versus placebo on the outcomes of trauma patients with significant hemorrhage. The main outcomes of interest were 24hour 30-day mortality and in-hospital thromboembolic complications. Two authors independently abstracted the data using a data collection form. Results from different studies were pooled for the analysis, when appropriate.

RESULTS: Out of 92 references identified through the search, two analytical studies met the inclusion criteria. The effect of TXA on 24-hour mortality had a pooled odds ratio (OR) of 0.49 (95% CI 0.28-0.85), 30-day mortality OR of 0.86 (95% CI, 0.56-1.32), and thromboembolic events OR of 0.74 (95% CI, 0.27-2.07).

CONCLUSION: Prehospital TXA appears to reduce early mortality in trauma patients. The pooled analysis also shows a trend toward lower 30-day mortality and reduced risk of thromboembolic events. Additional randomized controlled clinical trials are needed to determine the significance of these trends.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. El-Menyar A, Sathian B, Asim M, et al. Efficacy of prehospital administration of tranexamic acid in trauma patients: A meta-analysis of the randomized controlled trials. Am J Emerg Med. 2018. PMID: 29573898. doi:10.1016/j.ajem.2018.03.033

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。